Status:
COMPLETED
Efficacy and Safety on the Use of Bisphosphonates in Paediatrics
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Bone Fragile
Bisphosphonate-Associated Osteonecrosis
Eligibility:
All Genders
Up to 18 years
Brief Summary
The investigators suppose that the impact of bisphosphonate therapy is beneficial on the bone during the growth period with few adverse events.
Eligibility Criteria
Inclusion
- be under 18 years of age
- have been treated by intravenous bisphosphonates for primary or secondary osteoporosis
Exclusion
- be over 18 years of age
Key Trial Info
Start Date :
October 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04012320
Start Date
October 31 2018
End Date
December 31 2018
Last Update
July 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUNimes
Nîmes, France